BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9777173)

  • 1. Inositol levels are decreased in postmortem brain of schizophrenic patients.
    Shimon H; Sobolev Y; Davidson M; Haroutunian V; Belmaker RH; Agam G
    Biol Psychiatry; 1998 Sep; 44(6):428-32. PubMed ID: 9777173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder.
    Shimon H; Agam G; Belmaker RH; Hyde TM; Kleinman JE
    Am J Psychiatry; 1997 Aug; 154(8):1148-50. PubMed ID: 9247405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scyllo-inositol in post-mortem brain of bipolar, unipolar and schizophrenic patients.
    Shapiro J; Belmaker RH; Biegon A; Seker A; Agam G
    J Neural Transm (Vienna); 2000; 107(5):603-7. PubMed ID: 11072754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of myo-inositol monophosphatase in Alzheimer's disease brains.
    Shimohama S; Tanino H; Sumida Y; Tsuda J; Fujimoto S
    Neurosci Lett; 1998 Apr; 245(3):159-62. PubMed ID: 9605480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of calbindin D28k and inositol monophosphatase in human postmortem cortex: possible implications for bipolar disorder.
    Shamir A; Elhadad N; Belmaker RH; Agam G
    Bipolar Disord; 2005 Feb; 7(1):42-8. PubMed ID: 15654931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inositol monophosphatase activity in brain and lymphocyte-derived cell lines of bipolar patients.
    Shaltiel G; Shamir A; Nemanov L; Yaroslavsky Y; Nemets B; Ebstein RP; Belmaker RH; Agam G
    World J Biol Psychiatry; 2001 Apr; 2(2):95-8. PubMed ID: 12587191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ziskind-Somerfeld Research Award 1993. Biochemical, behavioral, and clinical studies of the role of inositol in lithium treatment and depression.
    Kofman O; Belmaker RH
    Biol Psychiatry; 1993 Dec; 34(12):839-52. PubMed ID: 8110911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid inositol monophosphatase: elevated activity in depression and neuroleptic-treated schizophrenia.
    Atack JR; Levine J; Belmaker RH
    Biol Psychiatry; 1998 Sep; 44(6):433-7. PubMed ID: 9777174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.
    Faraci WS; Zorn SH; Bakker AV; Jackson E; Pratt K
    Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):369-74. PubMed ID: 8387266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical and kinetic mechanism of the inositol monophosphatase reaction and its inhibition by Li+.
    Leech AP; Baker GR; Shute JK; Cohen MA; Gani D
    Eur J Biochem; 1993 Mar; 212(3):693-704. PubMed ID: 8385008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of ECS on rat brain inositol monophosphatase activity and inositol levels and of i.c.v. inositol on ictal and post-ictal length.
    Patishi Y; Agam G; Tardov M; Kofman O; Belmaker RH
    J Psychiatr Res; 1996; 30(1):39-43. PubMed ID: 8736465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dephosphorylation of inositol 1,4-bisphosphate to inositol in liver and brain involves two distinct Li+-sensitive enzymes and proceeds via inositol 4-phosphate.
    Ragan CI; Watling KJ; Gee NS; Aspley S; Jackson RG; Reid GG; Baker R; Billington DC; Barnaby RJ; Leeson PD
    Biochem J; 1988 Jan; 249(1):143-8. PubMed ID: 2829849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The purification and properties of myo-inositol monophosphatase from bovine brain.
    Gee NS; Ragan CI; Watling KJ; Aspley S; Jackson RG; Reid GG; Gani D; Shute JK
    Biochem J; 1988 Feb; 249(3):883-9. PubMed ID: 2833231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK-3 parameters in postmortem frontal cortex and hippocampus of schizophrenic patients.
    Nadri C; Dean B; Scarr E; Agam G
    Schizophr Res; 2004 Dec; 71(2-3):377-82. PubMed ID: 15474909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330.
    Atack JR; Cook SM; Watt AP; Fletcher SR; Ragan CI
    J Neurochem; 1993 Feb; 60(2):652-8. PubMed ID: 8380439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased [3H] raclopride binding sites in postmortem brains from schizophrenic violent suicide victims.
    Ruiz J; Gabilondo AM; Meana JJ; GarcĂ­a-Sevilla JA
    Psychopharmacology (Berl); 1992; 109(4):410-4. PubMed ID: 1365855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in puromycin-sensitive aminopeptidases in postmortem schizophrenic brain regions.
    Hui M; Budai ED; Lajtha A; Palkovits M; Hui KS
    Neurochem Int; 1995; 27(4-5):433-41. PubMed ID: 8845744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of inositol monophosphatase in Saccharomyces cerevisiae.
    Murray M; Greenberg ML
    Mol Microbiol; 1997 Aug; 25(3):541-6. PubMed ID: 9302016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronically administered lithium alters neither myo-inositol monophosphatase activity nor phosphoinositide levels in rat brain.
    Honchar MP; Ackermann KE; Sherman WR
    J Neurochem; 1989 Aug; 53(2):590-4. PubMed ID: 2545823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dictyostelium discoideum contains three inositol monophosphatase activities with different substrate specificities and sensitivities to lithium.
    Van Dijken P; Bergsma JC; Hiemstra HS; De Vries B; Van Der Kaay J; Van Haastert PJ
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):491-5. PubMed ID: 8670062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.